Abstract:The success of cancer gene therapy highly relies on the gene delivery vector with high transfection activity and low toxicity. In the present study, eight-armed polyethylene glycol (EAP) and low molecular weight (LMW) polyethylenimine (PEI) were used as basic units to construct the architecture of a new star-shaped EAP-PEI copolymer (EAPP). MC11, a peptide capable of selectively binding fibroblast growth factor receptor (FGFR) on tumor cell membranes, was further conjugated to EAPP to produce the vector EAPP-MC11 (EAPPM) to enhance tumor targetability. This tumor-targeting vector EAPPM was observed to retard the plasmids mobility at a nitrogen/phosphorus (N/P) ratio of 3. The vector could efficiently condense plasmids within 300 nm nanoparticles with a positive zeta potential at the N/P ratio of 20 or above. While the cytotoxicity of EAPPM polyplexes was similar to that of LMW PEI, it was significantly lower than that of PEI (25 kDa) in HepG2 and PC3 cell lines. In vitro gene transfection with pDNA mediated by EAPPM showed that the transfection efficiency increased 15 times in HepG2 cells but remained at a similar level in PC3 cells in comparison with that of EAPP. By systemic injection of EAPPM/pDNA complexes into a HepG2-bearing mice model, luciferase expression detected in lung, liver, and tumor tissues demonstrated EAPPM could deliver in a targeted manner a reporter gene into tumor tissues, where the luciferase expression of EAPPM was 4 times higher than that of EAPP and even 23 times higher than that of PEI (25 kDa). Furthermore, it was found that the systemic delivery of EAPPM/pCSK-α-interferon complexes in vivo were much more effective in inhibiting tumor growth than EAPP or PEI (25 kDa). These results clearly show that EAPPM is an efficient and safe vector for FGFR-mediated targeted gene delivery both in vitro and in vivo. With low cytotoxicity and high targetability, EAPPM may have great potential as a delivery vector for future cancer gene therapy applications.

Construction of Recombinant FGFR1 Containing Full-Length Gene and Its Potential Application

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Expression and Purification of FGFR1-Fc Fusion Protein and Its Effects on Human Lung Squamous Carcinoma

AN ANTI-TUMOR RESEARCH OF RECOMBINANT PHAGE VACCINE EXPRESSED XENOGENIC EGFR

Construction of a Recombinant Human FGF1 Expression Vector for Mammary Gland-Specific Expression in Human Breast Cancer Cells

[Construction of Lentiviral Vector for Truncated Mouse Fibroblast Growth Factor Receptor-1 Gene and Its Expression in Eukaryotic Cells].

[Construction and Expression of Soluble Vascular Endothelial Growth Factor Receptor-1 Eukaryotic Expression Vector and Its Effect on Proliferation of Vascular Endothelial Cells].

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

Construction of Recombinant MT1F Overexpressed Plasmids and Validation of Their Transfection to RKO Colon Cancer Cells

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Construction and expression of recombinant plasmid TAZ-pcDNA3 .1 and TAZ-pEGFP-C2

Construction of Pgfp-Fl Plasmid and Its Application in Preparing FL-secreting Tumor Vaccine.

Cell-free expression and SMA copolymer encapsulation of a functional receptor tyrosine kinase disease variant, FGFR3-TACC3

Construction and Expression of Bfgf Gene Eukaryotic Cell Expression Vector

Construction and identification of eukaryotic expression vector of tissue factor pathway inhibitor-2 gene

Construction of a Recombinant Eukaryotic Vector Expressing Human Tumor Necrosis Factor Alpha

Construction of a Star-Shaped Copolymer As a Vector for FGF Receptor-Mediated Gene Delivery in Vitro and in Vivo.

Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.

Selection of Peptide Ligands Binding to Fibroblast Growth Factor Receptor 1.

Construction,Expression and Function of Recombinant Plasmid Expressing Human Hepatocyte Growth Factor Activator

Construction of Hbfgf Eukaryotic Expression Plasmid and Its Expression in Gingival Fibroblasts of Beagle